Skip to content

A pilot study for dose-finding of bFGF in the treatment of infertile patients with severe intrauterine adhesions or intrauterine scarring

A pilot study for dose-finding of bFGF in the treatment of infertile patients with severe intrauterine adhesions or intrauterine scarring

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OPC-17010786
Enrollment
Unknown
Registered
2017-03-05
Start date
2016-10-01
Completion date
Unknown
Last updated
2017-10-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

infertility caused by severe intrauterine adhesions or intrauterine scarring

Interventions

bFGF injection group:hysteroscopy followed by injection of bFGF

Sponsors

The Affiliated Drum Tower Hospital of Nanjing University Medical School
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1) Infertile patients in accordance with WHO diagnostic standard of infertility; 2) Patients with intrauterine adhesions for whom drugs and surgical interventions were ineffective , including severe intrauterine adhesions or severe intrauterine scarring or thin endometrium; 3) Aged 20-40 years old; 4) With clear fertility desires; 5) Normal ovarian function or with frozen embryos; 6) Willing to actively cooperate with postoperative follow-up.

Exclusion criteria

Exclusion criteria: 1) With abnormal chromosome karyotype; 2) With other uterine diseases including large intramural myomas,severe endometriosis,severe adenomyosis,severe congenital uterine malformations, endometrial tuberculosis,vaginitis and endometritis 3) Systemic diseases: hypertension, diabetes, and so on; 4) Contraindications to pregnancy; 5) Contraindications to hormone replacement therapy; 6) Medical history of pelvic tumors or receiving pelvic radiotherapy; 7) Involved in other clinical study; 8) Unable to adhere to the follow-up, or carrying on other treatment during follow-up period.

Design outcomes

Primary

MeasureTime frame
Pregnancy rate;Recovery of impaired endometrium;

Secondary

MeasureTime frame
Endometrial thickness and blood flow;Menstruation;

Countries

China

Contacts

Public ContactYali Hu

The Affiliated Drum Tower Hospital of Nanjing University Medical School

glyyhuyali@163.com+86 13951846008

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026